🇺🇸 US Stock Screener ← Switch market ⚡ HerAI

American Shared Hospital Services AMS PHARMA

Healthcare · Medical Care Facilities · United States
https://www.ashs.com
Company Profile ↓
$1.42
-44.96% 1Y
Mkt Cap$9.44M
P/E-5.46
P/B0.43
52W High$3.04
52W Low$1.29
Book Value$3.49
EPS (TTM)$-0.26

Company Overview

American Shared Hospital Services provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. It operates in two segments: Leasing and Direct Patient Service. The company leases nine Gamma Knife systems and one proton beam radiation therapy (PBRT) system; and provides planning, installation, reimbursement, and marketing support services. It also owns and operates two single-unit Gamma Knife facilities that provides radiosurgery services directly to the patient. The company markets its solutions to cancer treatment centers, health systems, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.

Why Investors Should Care

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $28.08M (-0.9% YoY); net profit $-1.55M.
  • Trailing 12 Months Year-on-year growth — revenue +19.2%, earnings -171.0%.
  • 5-Year Trend Long-term compounding — revenue CAGR 9.5%.

Growth & Price Performance

Compounded Sales Growth

5 Years:9.50%
1 Year:19.20%

Compounded Profit Growth

5 Years:-
1 Year:-171.04%

Stock Price Performance

1 Year:-44.96%
6 Months:-32.38%
3 Months:+9.23%
1 Month:-4.70%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 7% of range
$1.29 $3.04
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)43.14 · Neutral
Price Performance
1M-4.70%
3M+9.23%
6M-32.38%
1Y-44.96%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Generates positive free cash flow.

CONS

  • Trading 53.3% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-5.46
Industry PE
24.83
Forward P/E
3.55
PEG Ratio
-
Book Value
$3.49
Price to Book
0.43
P/S
0.33
EV/EBITDA
8.35
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
9.50%
Profit 5Y
-
Revenue (YoY)
19.20%
Earnings (YoY)
-171.04%

Profitability & Returns

ROCE
-11.20%
ROE
-12.06%
ROA
-2.44%
Profit Margin
-5.83%
Op Margin
-7.22%
Gross Margin
34.83%
EPS (Latest Qtr)
$-0.09
EPS (TTM)
$-0.26

Balance Sheet & Liquidity

Debt/Equity
0.80
Quick Ratio
0.73
Current Ratio
0.78
Debt
$20.52M
Total Assets
$54.73M
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
34.72%
Chg in Prom Hold
-0.13%
FII / Inst Holding
7.63%
Chg in FII Hold
-7.46%

Financial Snapshot

Enterprise Value
$9.44M
Total Revenue (TTM)
$30.41M
EBITDA
$3.13M
Free Cash Flow
$4.47M
Operating Cash Flow
$5.35M
Shares Outstanding
6.65M
Gross Margin
34.83%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 AMS American Shared Hospital Services PHARMA 1.42 -5.46 $9.44M 0.00% -11.20% -12.06% 9.50% -
2 LLY Eli Lilly and Company SPXR3KPHARMA 1,123.91 37.80 $1.00T 0.60% - 102.29% 7.20% 11.41%
3 JNJ Johnson & Johnson SPXR3KPHARMA 269.12 31.22 $648.55B 1.98% 14.88% 25.74% 2.43% 4.76%
4 ABBV AbbVie Inc. SPXR3KPHARMA 248.78 70.48 $439.62B 2.78% 10.47% -129.24% 1.75% -29.06%
5 MRK Merck & Co., Inc. SPXR3KPHARMA 148.46 118.77 $366.28B 2.31% - 6.96% 5.64% 10.01%
6 UNH UnitedHealth Group Incorporated SPXR3KPHARMA 400.84 25.74 $359.79B 2.47% 9.74% 14.15% 10.40% 5.43%
7 NVS Novartis AG PHARMA 137.70 20.80 $261.73B 3.36% 21.09% 30.35% 9.25% 26.22%
8 AZN AstraZeneca PLC NDXPHARMA 160.04 23.99 $248.20B 2.00% 15.97% 21.96% 9.82% 45.96%
9 TMO Thermo Fisher Scientific Inc. SPXR3KPHARMA 603.02 32.49 $222.97B 0.29% 8.14% 13.51% 8.81% 12.95%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2013Jun 2013Sep 2013Mar 2014Jun 2014Sep 2014Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue ----------------5.17M4.47M-5.20M5.30M4.57M3.99M4.67M4.36M4.48M4.10M4.85M5.03M4.83M4.92M5.57M5.13M5.22M7.06M7.00M6.11M7.07M7.17M7.08M
Gross Profit 2.12M1.89M1.58M1.29M845.00K1.60M1.60M1.80M1.45M1.73M1.84M2.40M2.35M2.25M1.88M2.21M2.08M1.63M1.94M1.73M1.81M1.39M907.00K1.14M1.43M1.61M1.47M2.07M2.09M1.96M1.91M2.52M2.10M2.14M2.47M1.37M942.00K1.63M1.59M1.29M
Operating Income 412.00K284.00K162.00K-103.00K-602.00K274.00K456.00K478.00K315.00K499.00K443.00K896.00K754.00K669.00K439.00K795.00K643.00K185.00K515.00K302.00K446.00K-99.00K-570.00K-251.00K90.00K352.00K186.00K600.00K793.00K448.00K98.00K-325.00K90.00K-85.00K-1.00K-889.00K-1.30M-544.00K-344.00K-924.00K
Net Income 25.00K-122.00K-134.00K-96.00K-927.00K13.00K128.00K-1.97M43.00K51.00K93.00K334.00K293.00K113.00K99.00K390.00K287.00K168.00K270.00K31.00K165.00K-135.00K-483.00K-209.00K29.00K-87.00K33.00K269.00K497.00K316.00K188.00K-111.00K118.00K119.00K3.60M-207.00K-625.00K-280.00K-17.00K-612.00K
Diluted EPS 0.01-0.03-0.03-0.02-0.200.000.02-0.360.010.010.020.060.050.020.020.070.050.030.050.010.03-0.02-0.08-0.030.00-0.010.010.040.080.050.03-0.020.020.020.55-0.03-0.10-0.040.00-0.09

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 016.68M22.22M17.05M17.58M15.42M16.55M18.70M19.56M19.71M20.61M17.84M17.63M19.75M21.32M28.34M28.08M
Gross Profit 6.99M7.21M8.00M6.93M6.94M5.28M6.71M8.79M8.66M7.49M6.92M4.47M6.73M8.38M9.34M9.19M5.06M
Operating Income 653.00K865.00K1.59M730.00K1.12M-50.00K1.98M3.29M2.41M1.86M1.54M-9.46M1.35M2.43M270.00K-2.81M-3.59M
Net Income -188.00K57.00K506.00K38.00K-312.00K-952.00K-1.52M930.00K1.92M1.02M659.00K-7.06M194.00K1.33M610.00K2.19M-1.55M
Diluted EPS -0.040.010.110.01-0.07-0.19-0.280.170.330.170.11-1.140.030.210.100.33-0.23

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --65.34M74.53M73.32M71.74M67.53M54.11M60.60M58.18M57.50M53.78M43.65M45.43M43.96M48.16M60.20M55.48M
Total Equity 22.94M22.75M19.57M20.20M19.93M19.62M21.43M20.13M21.50M23.86M25.10M26.03M19.27M19.89M21.62M22.62M25.18M24.03M
Cash & Equivalents ---2.58M1.56M1.91M1.06M2.21M2.87M2.15M1.44M1.43M3.96M8.14M12.34M13.69M11.03M3.46M
Long Term Debt ---15.37M17.77M15.54M10.72M9.60M5.11M3.60M3.33M1.95M3.44M14.32M12.21M11.04M17.34M0
Total Liabilities ----45.21M24.38M19.37M------21.19M18.33M21.88M30.17M27.79M
Current Liabilities --7.44M9.94M9.65M11.79M16.25M8.70M8.68M9.01M9.47M8.21M12.38M5.89M5.17M10.78M10.40M23.44M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 7.70M7.18M6.85M6.87M8.08M-8.55M8.38M7.85M8.06M8.05M9.74M6.27M7.24M5.72M167.00K3.10M
Investing Cash Flow -10.14M-315.00K-5.65M-6.67M-1.72M--910.00K-1.04M-653.00K-1.53M-990.00K-2.39M-1.67M-388.00K-6.27M-7.11M-7.63M
Financing Cash Flow -7.01M-6.26M-29.00K-1.22M-6.02M--6.49M-6.47M-7.82M-7.25M-7.07M-4.81M-655.00K-2.66M1.91M4.41M-3.03M
Capital Expenditure -1.15M-315.00K-5.61M-6.63M-1.71M-5.21M-900.00K-1.04M-803.00K-1.58M-990.00K-455.00K-1.67M-388.00K-6.27M-7.94M-7.63M
Free Cash Flow 6.56M6.87M1.24M235.00K6.37M-7.65M7.34M7.05M6.49M7.06M9.29M4.59M6.85M-555.00K-7.77M-4.54M
Share Buybacks 271.00K0028.00K02.00K00---------

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -43.2%36.0%40.6%39.5%34.2%40.6%47.0%44.3%38.0%33.6%25.0%38.2%42.4%43.8%32.4%18.0%
Operating Margin % -5.2%7.2%4.3%6.4%-0.3%12.0%17.6%12.3%9.4%7.5%-53.1%7.7%12.3%1.3%-9.9%-12.8%
Net Margin % -0.3%2.3%0.2%-1.8%-6.2%-9.2%5.0%9.8%5.2%3.2%-39.6%1.1%6.7%2.9%7.7%-5.5%
ROE % -0.8%0.3%2.5%0.2%-1.6%-4.4%-7.6%4.3%8.1%4.1%2.5%-36.6%1.0%6.1%2.7%8.7%-6.5%
ROCE % -1.5%2.5%1.1%1.9%-0.1%4.4%6.3%4.9%3.9%3.4%-30.3%3.4%6.3%0.7%-5.6%-11.2%

Shareholding Pattern

Insiders
34.72%
Institutions
7.63%
Public Float
11.69%

Top Institutional Holders

#Holder% HeldSharesValue
1 Dimensional Fund Advisors LP 1.54% 102.14K $145.04K
2 LPL Financial LLC 1.22% 81.39K $115.57K
3 Renaissance Technologies, LLC 0.87% 57.70K $81.93K
4 Vanguard Capital Management LLC 0.84% 55.66K $79.04K
5 NewEdge Advisors, LLC 0.45% 29.73K $42.21K
6 James Investment Research, Inc. 0.45% 29.73K $42.21K
7 Bridgeway Capital Management, LLC 0.44% 29.12K $41.36K
8 Geode Capital Management, LLC 0.40% 26.50K $37.62K
9 Vanguard Fiduciary Trust Co 0.38% 25.36K $36.02K
10 Xtx Topco Ltd 0.29% 19.11K $27.13K

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for AMS

Yahoo Finance ue, 08 Sep 2026

Novartis Trial Failure Sparks Biopharma Options Frenzy

3 biopharma stocks seeing high options volume

Yahoo Finance Mon, 07 Sep 2026

Form 8.3

LONDON, September 07, 2026-- FORM 8.3

AMS — Frequently Asked Questions

What is the current share price of American Shared Hospital Services (AMS)?

As of 2026-09-19 21:16 PDT, American Shared Hospital Services (AMS) trades at $1.42 on NYSE American. Its 52-week range is $1.29 to $3.04.

What is the market capitalisation of AMS?

American Shared Hospital Services (AMS) has a market capitalisation of $9.44M on NYSE American.

What is the P/E ratio of AMS?

AMS trades at a trailing price-to-earnings (P/E) ratio of -5.46. The industry average P/E is 24.83. Its price-to-book (P/B) ratio is 0.43.

What is the return on equity (ROE) of AMS?

AMS has a return on equity (ROE) of -12.06%. Its return on capital employed (ROCE) is -11.20%.

Is AMS a good stock to buy?

This page provides a data-driven analysis of American Shared Hospital Services (AMS), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space